Verition Fund Management
DFTX

Verition Fund Management’s Definium Therapeutics DFTX Stock Holding History

Verition Fund Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$196K Sell
10,384
-121,879
-92% -$2.07M ﹤0.01% 1955
2025
Q4 		$1.77M Buy
+132,263
New +$1.64M 0.01% 1720

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Verition Fund Management's DFTX Position: Q1 2026 in Review

Verition Fund Management reduced its Definium Therapeutics (DFTX) stake by 92% in Q1 2026, selling an estimated $2.07M and leaving 10,384 shares worth $196K. The position accounts for ﹤0.01% of the portfolio, ranked #1955.

Verition Fund Management first reported a position in DFTX in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.77M in Q4 2025. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Verition Fund Management held 10,384 shares of Definium Therapeutics worth $196K as of Q1 2026.
  • Verition Fund Management sold 121,879 Definium Therapeutics shares in Q1 2026, an estimated $2.07M.
  • Definium Therapeutics made up ﹤0.01% of Verition Fund Management's portfolio in Q1 2026, its #1955 holding.
  • Verition Fund Management first reported a position in Definium Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Verition Fund Management's Definium Therapeutics position peaked at $1.77M in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.